middle.news
How Will Anteris’ $230M Raise Accelerate Its DurAVR Heart Valve Breakthrough?
3:12pm on Thursday 22nd of January, 2026 AEDT
•
Healthcare
Read Story
How Will Anteris’ $230M Raise Accelerate Its DurAVR Heart Valve Breakthrough?
3:12pm on Thursday 22nd of January, 2026 AEDT
Key Points
Public offering of 34.8 million shares at $5.75 each
Concurrent private placement of 15.7 million shares to Medtronic subsidiary
Funding to support PARADIGM pivotal trial and manufacturing expansion
DurAVR THV System targets aortic stenosis with biomimetic valve technology
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anteris Technologies Global (ASX:AVR)
OPEN ARTICLE